Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutationAlberto Álvarez‐Larrán, C. Besses, Eduardo Arellano‐Rodrigo et al.|Haematologica|2016Cited by 149
Symptomatic burden in myelofibrosis (MF): Prospective international assessment in 128 MF patients.R. Scherber, Ruben A. Mesa, A. C. Dueck et al.|Journal of Clinical Oncology|2011Cited by 4